Extravascular renal denervation
1 paper studies it1 finding
1 new paper in 30 daysSee all 1 papers on extravascular renal denervation
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“After eRDN, median 24-hour ASBP decreased from 146.0 mmHg (interquartile range [IQR] 140.0–161.0) at baseline to 124.0 mmHg (IQR 116.0–131.0) at 3 months.”
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave extravascular renal denervation to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases 24-hour ambulatory systolic blood pressureMedian 24-hour ASBP: 146.0 mmHg (IQR 140.0–161.0) at baseline versus 124.0 mmHg (IQR 116.0–131.0) at 3 months | Trial3 months | 9 people20–80 yearsResistant hypertension despite three or more antihypertensive drugs, including a diuretic; single-arm comparison with baseline | ESC Congress 2026 abstract, Oct 26, 2026 |
What did studies of extravascular renal denervation find?
1Studies of extravascular renal denervation measured one outcome, 24-hour ambulatory systolic blood pressure.
24-hour ambulatory systolic blood pressure
downin humans1
1 study
24-hour ambulatory systolic blood pressure
downin humans1
Extravascular renal denervation decreases 24-hour ambulatory systolic blood pressure in humans (Median 24-hour ASBP: 146.0 mmHg (IQR 140.0–161.0) at baseline versus 124.0 mmHg (IQR 116.0–131.0) at 3 months).
“After eRDN, median 24-hour ASBP decreased from 146.0 mmHg (interquartile range [IQR] 140.0–161.0) at baseline to 124.0 mmHg (IQR 116.0–131.0) at 3 months.”
Human trialresistant hypertension despite three or more antihypertensive drugs, including a diuretic; single-arm comparison with baselineextravascular3 monthsn = 9
ESC Congress 2026 abstract